Zobrazeno 1 - 10
of 30
pro vyhledávání: '"María Giselle, Peters"'
Autor:
Damian Emilio Berardi, Lizeth Ariza Bareño, Natalia Amigo, Luciana Cañonero, Maria de las Nieves Pelagatti, Andrea Nora Motter, María Agustina Taruselli, María Inés Díaz Bessone, Stefano Martin Cirigliano, Alexis Edelstein, María Giselle Peters, Miriam Diament, Alejandro Jorge Urtreger, Laura Beatriz Todaro
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-17 (2021)
Abstract Breast cancer is the leading cause of cancer death among women worldwide. Blocking a single signaling pathway is often an ineffective therapy, especially in the case of aggressive or drug-resistant tumors. Since we have previously described
Externí odkaz:
https://doaj.org/article/01e93465ea7b4915836df1684987bcd4
Autor:
Laura B. Todaro, Stefano M. Cirigliano, María Giselle Peters, Damian E. Berardi, Damian Ignacio Delbart, Alejandro J. Urtreger, María I. Díaz Bessone
Purpose: Retinoids have proved to be effective for hematologic malignancies treatment but till nowadays, their use as single agent for the solid tumor’s management is still controversial. All-trans retinoic acid (ATRA), the main active metabolite o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3300b46fbad155e1b2e1f0b588fe2c5
https://link.springer.com/article/10.1007/s00432-020-03368-7
https://link.springer.com/article/10.1007/s00432-020-03368-7
Autor:
María Inés Díaz, Bessone, Damián Emilio, Berardi, Stéfano Martín, Cirigliano, Damián Ignacio, Delbart, María Giselle, Peters, Laura Beatriz, Todaro, Alejandro Jorge, Urtreger
Publikováno v:
Journal of cancer research and clinical oncology. 146(12)
Retinoids have proved to be effective for hematologic malignancies treatment but till nowadays, their use as single agent for the solid tumor's management is still controversial. All-trans retinoic acid (ATRA), the main active metabolite of vitamin A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::961da39f12a63c8fc9880022471a6ca3
https://pubmed.ncbi.nlm.nih.gov/32865619
https://pubmed.ncbi.nlm.nih.gov/32865619
Autor:
Luciana Cañonero, Andrea Motter, María Agustina Taruselli, Maria de Las Nieves Pelagatti, Lizeth Ariza Bareño, Natalia Loreley Amigo, Miriam J. Diament, Stefano M. Cirigliano, María Giselle Peters, Alexis Edelstein, Laura B. Todaro, Damian E. Berardi, Alejandro J. Urtreger, María I. Díaz Bessone
Publikováno v:
Scientific Reports
Scientific Reports, Vol 11, Iss 1, Pp 1-17 (2021)
Scientific Reports, Vol 11, Iss 1, Pp 1-17 (2021)
Breast cancer is the leading cause of cancer death among women worldwide. Blocking a single signaling pathway is often an ineffective therapy, especially in the case of aggressive or drug-resistant tumors. Since we have previously described the mecha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1139227d176b6a921f7dde4c506f5b85
https://pubmed.ncbi.nlm.nih.gov/33723318
https://pubmed.ncbi.nlm.nih.gov/33723318
Autor:
Laura B. Todaro, Ana Clara Lugones, Alejandro J. Urtreger, Macarena Guereño, Magalí Cecilia Cercato, María Giselle Peters, Magali Delgado Pastore
Publikováno v:
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
GPC3 is a proteoglycan involved in the control of proliferation and survival, which has been linked to several tumor types. In this respect, we previously demonstrated that normal breast tissues exhibit high levels of GPC3, while its expression is di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b119769280b9cb86a5197757b8eb07f
https://pubmed.ncbi.nlm.nih.gov/32800275
https://pubmed.ncbi.nlm.nih.gov/32800275
Publikováno v:
Cancer Research. 80:2720-2720
GPC3 is a proteoglycan involved in the control of proliferation and survival, which has been linked to cancer. In this respect, we previously demonstrated that normal breast tissues exhibit high levels of GPC3, while its expression is diminished in t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::54e78c42ccb42a886351e684886cc637
https://doi.org/10.1158/1538-7445.am2020-2720
https://doi.org/10.1158/1538-7445.am2020-2720
Autor:
María Giselle Peters, María Amparo Lago Huvelle, Magalí Cecilia Cercato, Dolores Fernandez, Macarena Guereño
Purpose: We have shown that GPC3 overexpression in breast cancer cells inhibits in vivo tumor progression, by acting as a metastatic suppressor. GPC3-overexpressing cells are less clonogenic, viable and motile, while their homotypic adhesion is incre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b59a5fc0758b64a0019bd168239a45be
https://link.springer.com/article/10.1007/s00432-018-2751-0
https://link.springer.com/article/10.1007/s00432-018-2751-0
Autor:
Dolores, Fernández, Macarena, Guereño, María Amparo, Lago Huvelle, Magalí, Cercato, María Giselle, Peters
Publikováno v:
Journal of cancer research and clinical oncology. 144(12)
We have shown that GPC3 overexpression in breast cancer cells inhibits in vivo tumor progression, by acting as a metastatic suppressor. GPC3-overexpressing cells are less clonogenic, viable and motile, while their homotypic adhesion is increased. We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::67cd52c191f29fdf3533656340b76762
https://pubmed.ncbi.nlm.nih.gov/30267212
https://pubmed.ncbi.nlm.nih.gov/30267212
Autor:
María Candelaria Llorens, María A. Lago Huvelle, Jorge Shortrede, Rocio Tascon, Lilian Fedra Castillo, Leticia Labriola, Ancély Ferreira dos Santos, Ana M. Cabanillas, María Giselle Peters, Gisela V. Novack, Elisa Bal de Kier Joffé
Publikováno v:
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
Oncotarget
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
Oncotarget
Breast cancer is the disease with the highest impact on global health, beingmetastasis the main cause of death. To metastasize, carcinoma cells must reactivate a latent program called epithelial-mesenchymal transition (EMT), through which epithelial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7ed82d45b85351aeb68576fd277ad61
http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=view&path[]=11107&pubmed-linkout=1
http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=view&path[]=11107&pubmed-linkout=1
Publikováno v:
Current Pharmaceutical Biotechnology. 12:1948-1960
Tumor metastasis is a main contributor to death in cancer patients. In the last years, a new class of molecules that reduces the metastatic propensity has been identified: metastasis suppressors. These proteins regulate multiple steps in the metastat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0d85292d53b200f87d052a4b8dd48ad
https://doi.org/10.2174/138920111798376914
https://doi.org/10.2174/138920111798376914